This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

  1. Tool
  2. Source: Campus Sanofi
  3. 3 Feb 2025
3 min

SCORAD

Author: Sanofi

Prescribers writing on a clipboard

DUPIXENT (dupilumab) Prescribing Information UK

SCORAD (SCORing Atopic Dermatitis), developed by the European Task Force on Atopic Dermatitis and published in 1993, is a widely used and well-validated tool.1, 2

This composite score integrates both physician and patient observations:

  1. Body surface area affected by AD,
  2. The severity of the 6 clinical signs (erythema, induration/papules, oozing/crusting, excoriation, lichenification, dryness),
  3. Pruritus and sleep disturbances reported by the patient.1

 

In routine clinical practice, it takes 3 to 9 minutes to complete a SCORAD score.3

This offers the advantage of:

  • Carry out a complete systematic examination
  • Compare with previous scores to adapt the therapeutic decision.

The score ranges from 0 to 103 (most severe state) and is used to determine the stages of AD severity:1, 4

Atopic dermatitis

Mild

Moderate

Severe

Score

< 25

25 - 50

> 50

References
  1. Gooderham MJ, et al Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section II: Tools for assessing the severity of atopic dermatitis. J Cutan Med Surg. 2018; 22(1_suppl), 10S-16S.
  2. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23-31.
  3. Chopra R, et al. Relationship between EASI and SCORAD severity assessments for atopic dermatitis. J Allergy Clin Immunol. 2017 Dec;140(6):1708-1710.e1.
  4. Oranje, AP. et al Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three‐item severity score, British Journal of Dermatology. 2007;157(4):645-648.
Photo of the paper ADCT test

Atopic Dermatitis Control Test (ADCT)

Atopic dermatitis, a type of eczema, may be affecting your patient’s life in more ways than you know.

The ADCT gives a measure of how controlled your patient’s eczema is. Use these 6 concise questions to evaluate all dimensions of atopic dermatitis control.

Development of ADCT involved literature review as well as interviews with patients and physicians, and was funded by Sanofi and Regeneron.

Try the ADCT

MAT-XU-2304526 (v1.0) Date of Preparation: February 2025